JANSSEN BIOTECH, INC.
HORSHAM, PA

Janssen Biotech, Inc. is a leading pharmaceutical company based in Horsham, Pennsylvania, operating as part of the global Janssen Pharmaceutical Companies of Johnson & Johnson. The company focuses on innovating solutions to address some of the world's most challenging diseases across multiple therapeutic areas. It maintains its corporate presence under the jurisdiction of Florida with a filing number of F12000000277 and is registered as a Foreign for-profit corporation (FORP). Janssen Biotech was incorporated on January 20, 2012. The company holds responsibility not only through its global services arm but also engages actively with stakeholders by providing accurate scientific information about its products via the JanssenMD™ site. This platform is intended for U.S. healthcare professionals to offer access to scientifically vetted data and clinical resources. The contact points at Janssen Biotech include phone numbers (800) 526-7736, (908) 218-6095, and (609) 730-2378, with its mailing address being P.O. Box 2317, Horsham, PA 19044. Janssen Biotech is committed to addressing complex medical challenges through high-quality research and development, adhering to ethical pharmaceutical practices and emphasizing patient safety and well-being. The company's leadership includes officers such as Kevin J. Hamill (Director) and Robert McKeehan, Melissa Miller serving in associate roles, overseeing critical strategic decisions and operations. For more detailed information on the company's endeavors or specific product inquiries, stakeholders can refer to its official website at janssenbiotech.com. Its most recent annual report was filed in April 2024.